Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark N Adams

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Theranostics|October 24, 2022
CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapyTashbib Khan, Nicholas J Lyons, Madeline Gough, et al.
Cancers|September 28, 2021
Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung CancerKatherine B Sahin, Esha T Shah, Genevieve P Ferguson, et al.
British Journal of Cancer|February 17, 2016
Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancerBrittney S Harrington, Yaowu He, Claire M Davies, et al.
Oncogene|September 1, 2019
CDCP1 enhances Wnt signaling in colorectal cancer promoting nuclear localization of β-catenin and E-cadherinYaowu He, Claire M Davies, Brittney S Harrington, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Theranostics|October 24, 2022
CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapyTashbib Khan, Nicholas J Lyons, Madeline Gough, et al.
Cancers|September 28, 2021
Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung CancerKatherine B Sahin, Esha T Shah, Genevieve P Ferguson, et al.
British Journal of Cancer|February 17, 2016
Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancerBrittney S Harrington, Yaowu He, Claire M Davies, et al.
Oncogene|September 1, 2019
CDCP1 enhances Wnt signaling in colorectal cancer promoting nuclear localization of β-catenin and E-cadherinYaowu He, Claire M Davies, Brittney S Harrington, et al.
Pageof 6